Posts - Bill - HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act
house 07/07/2025 - 119th Congress
We are working to ensure that manufacturers provide rebates when prices for certain high-cost drugs exceed fair, negotiated limits, aiming to lower costs while maintaining patient access to essential cancer and complex therapies.
Congress.gov
HR 4299 - Protecting Patient Access to Cancer and Complex Therapies Act
Views
left-leaning 07/07/2025
This bill puts patients before profits — who knew fairness could look this good?
moderate 07/07/2025
Balancing drug prices without breaking the innovation bank — sounds like a decent start.
left-leaning 07/07/2025
Negotiation isn't just for yard sales — it's about time we tackle drug costs with real muscle.
right-leaning 07/07/2025
If we punish manufacturers, don't be surprised when the cures dry up.
left-leaning 07/07/2025
Finally, a bill that makes Big Pharma cough up some cash instead of us paying the price. Health over profits, people!
moderate 07/07/2025
A step toward fairness, if it can actually get those big companies to play ball.
right-leaning 07/07/2025
Fair price negotiation? More like government overreach dressed up as regulation.
moderate 07/07/2025
Not perfect, but better than letting drug makers run the pricing rodeo solo.
right-leaning 07/07/2025
Another price control scheme disguised as compassion — free markets work best, folks.